- Beat earnings estimates in all of the last 4 quarters
- +95.8% price growth over the last year
- Excellent financial health (Piotroski 7/9)
Stronger technical forecast for Teva Pharmaceutical Industries Limited stock price after Tuesday trading
(Updated on Jun 09, 2026)
The Teva Pharmaceutical Industries Limited stock price gained 3.58% on the last trading day (Tuesday, 9th Jun 2026), rising from $33.26 to $34.45. During the last trading day the stock fluctuated 4.76% from a day low at $32.91 to a day high of $34.48. The price has fallen in 7 of the last 10 days and is down by -0.46% for this period. Volume fell on the last day by -11 thousand shares and in total, 5 million shares were bought and sold for approximately $165.22 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 21.42% during the next 3 months and, with a 90% probability hold a price between $40.39 and $47.16 at the end of this 3-month period.
TEVA Signals & Forecast
The Teva Pharmaceutical Industries Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $33.84 and $34.17. A breakdown below any of these levels will issue sell signals. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, May 06, 2026, and so far it has fallen -5.20%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Teva Pharmaceutical Industries Limited stock
On the downside, the stock finds support just below today's level from accumulated volume at $31.26 and $30.47. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Teva Pharmaceutical Industries Limited finds support just below today's level at $31.26. If this is broken, then the next support from accumulated volume will be at $30.47 and $29.46.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.57 between high and low, or 4.76%. For the last week, the stock has had daily average volatility of 3.90%.
Our recommended stop-loss: $33.15 (-3.77%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 23 days ago.)
Trading Expectations (TEVA) For The Upcoming Trading Day Of Wednesday 10th
For the upcoming trading day on Wednesday, 10th we expect Teva Pharmaceutical Industries Limited to open at $33.95, and during the day (based on 14 day Average True Range), to move between $33.86 and $35.04, which gives a possible trading interval of +/-$1.18 (+/-3.48%) up or down from last closing price. If Teva Pharmaceutical Industries Limited takes out the full calculated possible swing range there will be an estimated 3.48% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $35.07 (1.80%) than the support at $31.26 (9.26%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Teva Pharmaceutical Industries Limited stock A Buy?
Teva Pharmaceutical Industries Limited holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.
Current score:
0.175
Hold/Accumulate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 10, 2026 - $33.95 ( 1.47%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
TEVA Performance
Trading levels for TEVA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 35.51 | 3.08% |
| R2 | 34.91 | 1.34% |
| R1 | 34.54 | 0.269% |
| Price | 34.45 | |
| S1 | 33.35 | -3.20% |
| S2 | 32.98 | -4.27% |
| S3 | 32.38 | -6.01% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 36.01 | 4.53% |
| R2 | 35.38 | 2.70% |
| R1 | 35.07 | 1.80% |
| Price | 34.45 | |
| S1 | 31.26 | -9.26% |
| S2 | 30.47 | -11.55% |
| S3 | 29.46 | -14.48% |
TEVA Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Nov 02, 2017 | Nov 27, 2017 | Dec 12, 2017 | $0.0850 | 0.515% |
| 2 | Aug 07, 2017 | Aug 25, 2017 | Sep 14, 2017 | $0.0850 | 0.463% |
| 3 | May 11, 2017 | Jun 01, 2017 | Jun 22, 2017 | $0.340 | 1.05% |
| 4 | Feb 13, 2017 | Feb 28, 2017 | Mar 20, 2017 | $0.340 | 1.01% |
| 5 | Nov 15, 2016 | Dec 01, 2016 | Dec 20, 2016 | $0.340 | 0.94% |
FAQ
Click here for our free guide on how to buy Teva Pharmaceutical Industries Limited Stock.
Buy TEVA